LY9 and colorectal carcinoma: Through multi‐omics analysis, we identified SLAMF3 expressed by CRC cells as a functional regulator that inhibited CRLM in mouse models, and its expression levels were positively correlated with poor survival in advanced‐stage CRC patients.